Filing Details
- Accession Number:
- 0001203311-20-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-11 18:51:29
- Reporting Period:
- 2020-03-09
- Accepted Time:
- 2020-03-11 18:51:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-09 | 100 | $12.00 | 758,884 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 100 | $113.29 | 758,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-09 | 900 | $12.00 | 759,684 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 900 | $112.53 | 758,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-09 | 3,926 | $12.00 | 762,710 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 3,926 | $111.47 | 758,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-09 | 9,797 | $12.00 | 768,581 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 9,797 | $110.79 | 758,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-09 | 8,661 | $12.00 | 767,445 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 8,661 | $109.75 | 758,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-09 | 2,386 | $12.00 | 761,170 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 2,386 | $108.68 | 758,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-09 | 953 | $12.00 | 759,737 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 953 | $107.53 | 758,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-09 | 1,549 | $12.00 | 760,333 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 1,549 | $106.87 | 758,784 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-03-09 | 200 | $12.00 | 758,984 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-03-09 | 200 | $105.29 | 758,784 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 100 | $0.00 | 100 | $12.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 900 | $0.00 | 900 | $12.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 3,926 | $0.00 | 3,926 | $12.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 9,797 | $0.00 | 9,797 | $12.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 8,661 | $0.00 | 8,661 | $12.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 2,386 | $0.00 | 2,386 | $12.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 953 | $0.00 | 953 | $12.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 1,549 | $0.00 | 1,549 | $12.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-03-09 | 200 | $0.00 | 200 | $12.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 170,735 | 2020-08-27 | No | 4 | M | Direct | |
| 169,835 | 2020-08-27 | No | 4 | M | Direct | |
| 165,909 | 2020-08-27 | No | 4 | M | Direct | |
| 156,112 | 2020-08-27 | No | 4 | M | Direct | |
| 147,451 | 2020-08-27 | No | 4 | M | Direct | |
| 145,065 | 2020-08-27 | No | 4 | M | Direct | |
| 144,112 | 2020-08-27 | No | 4 | M | Direct | |
| 142,563 | 2020-08-27 | No | 4 | M | Direct | |
| 142,363 | 2020-08-27 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $112.19 to $112.74. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $111.16 to $112.09. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $110.16 to $111.14. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $109.16 to $110.15. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected
- Reflects sales of common stock executed in multiple transactions at prices ranging from $108.14 to $109.09. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $107.11 to $107.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $106.11 to $107.10. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $105.00 to $105.57. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14.
Billionaire Hedge Funds
